Eli Lilly Comprehensive Income 2012-2026 | LLY

Eli Lilly comprehensive income for the quarter ending March 31, 2026 was $-2.880B, a 33.36% decline year-over-year.

  • Eli Lilly comprehensive income for 2025 was $-2.88B, a 33.36% decline from 2024.
  • Eli Lilly comprehensive income for 2024 was $-4.322B, a 0.12% decline from 2023.
  • Eli Lilly comprehensive income for 2023 was $-4.327B, a 12.55% increase from 2022.

Eli Lilly Comprehensive Income 2012-2026 | LLY

  • Eli Lilly comprehensive income for 2025 was $-2.88B, a 33.36% decline from 2024.
  • Eli Lilly comprehensive income for 2024 was $-4.322B, a 0.12% decline from 2023.
  • Eli Lilly comprehensive income for 2023 was $-4.327B, a 12.55% increase from 2022.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B